Mercado mundial de equipos de medicina nuclear: tendencias de la industria y pronóstico hasta 2031

Análisis y tamaño del mercado de equipos de medicina nuclear

El mercado de equipos de medicina nuclear está avanzando con innovaciones como los sistemas híbridos PET/MRI y las imágenes mejoradas con IA. Estas tecnologías mejoran la precisión del diagnóstico y los resultados de los pacientes. La creciente demanda de diagnósticos no invasivos y la creciente prevalencia de enfermedades crónicas impulsan el crecimiento del mercado. Los métodos más recientes incluyen la teranóstica, que combina terapia y diagnóstico, mejora la medicina personalizada y amplía las aplicaciones en oncología y cardiología.                                         

El tamaño del mercado mundial de equipos de medicina nuclear se valoró en USD 2.59 mil millones en 2023 y se proyecta que alcance los USD 4.35 mil millones para 2031, con una CAGR del 6,7% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Nuclear medicine equipment includes devices such as gamma cameras, PET scanners, and SPECT scanners. These machines use small amounts of radioactive materials to diagnose and treat diseases by capturing images of organs and tissues. They help in detecting conditions such as cancer, heart disease, and neurological disorders, providing crucial information for accurate diagnosis and treatment planning.            

Nuclear Medicine Equipment Market Dynamics

Drivers

• Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, significantly boosts the demand for nuclear medicine equipment. For instance, the increased incidence of cancer necessitates advanced imaging techniques such as PET scans for early diagnosis and treatment planning. This heightened need for precise diagnostic tools drives market growth, as healthcare providers invest more in nuclear medicine equipment to improve patient outcomes and manage chronic conditions effectively.

• Growing Adoption of Hybrid Imaging Systems

The growing adoption of hybrid imaging systems, which integrate nuclear medicine with modalities such as CT and MRI, significantly enhances diagnostic accuracy and efficiency. For instance, PET/CT scanners combine metabolic and anatomical imaging, providing comprehensive insights for cancer diagnosis and treatment planning. This integration not only improves patient outcomes but also drives demand for advanced nuclear medicine equipment, thereby fueling market growth.

Opportunities

• Advancement in Radiopharmaceuticals

Advancements in radiopharmaceuticals significantly enhance nuclear medicine procedures' effectiveness, driving market growth. For instance, the development of novel tracers such as Gallium-68 and Fluorine-18 allows for more accurate imaging and targeted therapy, improving patient outcomes. These innovations encourage healthcare providers to adopt advanced nuclear medicine equipment, thereby boosting the market as institutions seek to offer cutting-edge diagnostic and therapeutic options to their patients.

• Expansion of Applications

The expansion of nuclear medicine applications beyond oncology into fields such as cardiology and neurology significantly broadens the market. For instance, nuclear imaging techniques such as PET scans are now widely used to diagnose and monitor cardiac conditions and neurological disorders such as Alzheimer's disease. This diversification increases the utility and demand for nuclear medicine equipment, thereby driving market growth by appealing to a broader range of medical specialties and healthcare needs.

Restraints/Challenges

• High Cost of Equipment and Maintenance

The high cost of nuclear medicine equipment such as PET and SPECT scanners poses a significant barrier for smaller healthcare facilities and those in developing regions. These technologically advanced systems require substantial initial investment and ongoing maintenance expenses, limiting their adoption. This financial burden hinders market penetration and equitable access to advanced diagnostic capabilities in regions where healthcare infrastructure and funding are limited. 

• Shortage of Trained Personnel

The nuclear medicine equipment market faces hinderances due to a shortage of trained personnel. Operating such equipment demands specialized expertise, yet there is often a deficiency in qualified technologists and radiologists capable of interpreting nuclear imaging results. This scarcity restricts widespread adoption and utilization of these advanced technologies within healthcare facilities globally. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement to equip Mercurius Health’s Robert Janker Klinik cancer center in Bonn, Germany. Philips and Elekta will install advanced oncology diagnostic and therapeutic equipment, along with aligned informatics solutions, enhancing cancer care capabilities at the newly acquired facility
• In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based company specializing in Nuclear Medicine and Molecular Imaging equipment. This acquisition aims to bolster Mediso’s presence in the UK and Ireland markets, leveraging Bartec’s expertise in supply, installation, and support of medical imaging technologies
• In June 2022, Siemens Healthineers launched the Symbia Pro.specta, a SPECT/CT system with CE mark and FDA clearance. This advanced system integrates state-of-the-art SPECT and CT imaging technologies, featuring a low-dose CT capable of capturing detailed images with up to 64 slices, enhancing diagnostic accuracy and patient care
• In November 2022, Canon, Inc. announced the establishment of Canon Healthcare USA, INC., a new subsidiary aimed at expanding Canon’s footprint in the American medical market. This strategic move underscores Canon’s commitment to advancing its medical business through enhanced service offerings and innovative healthcare solutions in the U.S.

Nuclear Medicine Equipment Market Scope

The market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Single Photon-Emission Computed Tomography (SPECT)
  • Standalone
  • Hybrid
• Positron Emission Tomography (PET)
  • Standalone
  • Hybrid
• Planar Scintigraphy

 Application

• Cardiology
• Oncology
• Neurology
• General Imaging
• Others
  • Urology
  • Gastroenterology
  • Orthopedics

 End User

• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

Nuclear Medicine Equipment Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product type, application and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the nuclear medicine equipment market due to the rapid introduction of new radiopharmaceuticals for diagnostics and therapeutics in the region. The high growth in the U.S., driven by technological advancements, further strengthens its position as a key player in this evolving sector.

Asia-Pacific is expected to expand at a significant growth in the nuclear medicine equipment market, driven by Japan's highly developed nuclear medicine practice. The region sees a notable rise in hybrid SPECT/CT examinations, highlighting increasing adoption and technological advancements in medical imaging within this area.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

El mercado también le ofrece un análisis detallado del mercado para cada país: crecimiento del gasto sanitario en equipos de capital, base instalada de diferentes tipos de productos para el mercado, impacto de la tecnología mediante curvas de línea de vida y cambios en los escenarios regulatorios de la atención sanitaria y su impacto en el mercado. Los datos están disponibles para el período histórico 2016-2021.

Análisis del panorama competitivo y de la cuota de mercado de los equipos de medicina nuclear

El panorama competitivo del mercado proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Algunos de los principales actores que operan en el mercado son:

• CMR Naviscan (Estados Unidos)
• Compañía Mallinckrodt (Estados Unidos)
• Corporación Neusoft (China)
• DDD-Diagnostic A/S (Dinamarca)
•  CORPORACIÓN CANON MEDICAL SYSTEMS (Japón)
• Mediso Ltd. (Hungría)
• Soluciones de imágenes TTG (EE. UU.)
• Siemens Healthcare Private Limited (Alemania)
• Cardinal Health (Estados Unidos)
•  GE HealthCare (Estados Unidos)
• Koninklijke Philips NV (Países Bajos)
• Fujifilm (Japón)
• COMPAÑÍA MEXICANA DE RADIOLOGÍA (México)
• Biodex (Estados Unidos)
• Cyclopharm Limited (Australia)
•  Standard Imaging, Inc. (Estados Unidos)

SKU-1580